Stefania Giannelli

Medicine & Life Sciences

1. Genetic Therapy 100%
2. Wiskott-Aldrich Syndrome 99%
3. Stem Cells 42%
4. Cell- and Tissue-Based Therapy 40%
5. Hematopoietic Stem Cells 40%
6. Neuroferritinopathy 30%
7. Lymphopenia 28%
8. Ferroptosis 25%
9. Severe combined immunodeficiency due to adenosine deaminase deficiency 25%
10. Genes 24%
11. SARS Virus 23%
12. Myoclonic Epilepsy 22%
13. Clinical Studies 22%
14. Rhodopsin 20%
15. Adenosine Deaminase 20%
16. Clustered Regularly Interspaced Short Palindromic Repeats 20%
17. Retinitis Pigmentosa 19%
18. Epstein-Barr Virus Infections 19%
19. Kaposi's Sarcoma 19%
20. Hematology 18%
21. Germ-Line Mutation 18%
22. Autologous Transplantation 18%
23. Hematopoiesis 17%
24. Gene Deletion 17%
25. Interneurons 17%
26. Phosphatidylinositol 3-Kinases 16%
27. Rare Diseases 15%
28. Wiskott-Aldrich Syndrome Protein 15%
29. Safety 15%
30. Blood Platelets 15%
31. Transcriptional Activation 14%
32. Phenotype 14%
33. Epigenomics 14%
34. Iron 13%
35. Therapeutics 13%
36. Infections 13%
37. Registries 12%
38. Seizures 12%
39. Transcription Factors 12%
40. Severe Combined Immunodeficiency 12%
41. T-Lymphocytes 12%
42. Alleles 11%
43. Neurons 11%
44. In Vitro Techniques 11%
45. Bacillus 10%
46. IC 87114 10%
47. Haploinsufficiency 10%
48. Transplants 10%
49. NAV1.1 Voltage-Gated Sodium Channel 9%
50. Immune Reconstitution 9%